Kishiwada Masashi 岸和田昌之

… Alternative Names

岸和田昌之キシワダマサシ

KISHIWADA Masashi 岸和田昌之

Less

Researcher Number	40501961
Affiliation (Current)	2025: 三重大学, 医学部附属病院, 准教授
Affiliation (based on the past Project Information) *help	2024: 三重大学, 医学部附属病院, 准教授 2019 – 2022: 三重大学, 医学部附属病院, 准教授 2017 – 2018: 三重大学, 医学部附属病院, 講師 2012 – 2013: 三重大学, 医学部附属病院, 講師 2008 – 2011: Mie University, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator General surgery Except Principal Investigator Basic Section 58060:Clinical nursing-related / Basic Section 49020:Human pathology-related / Gastroenterology
Keywords	Principal Investigator 肝移植 / 虚血再還流障害 / 脂肪肝 / 凝固・抗凝固因子 / トロンボモジュリン / プロテインC / プロテインS / 活性化プロテインC / ドナー肝重量 / アダムTS13 … More / 凝固因子 / トロンボモジュリン(TM) / 虚血再環流 / 血栓性微小血管障害症 / ADAMTS13 / VWFpp / ADANMSTS13 / 可溶性トロンボモジュリン(rhsTM) / 血小板 / TPO / ADAMS13 / マージナルドナー / 生体肝移植 / 肝虚血再環流障害 / 微小循環障害 / 細胞単離 / ラット / TM / 類洞内皮障害 / 炎症反応 / 炎症性サイトカイン / Kuppfer細胞 / 類洞内皮細胞 / 肝細胞 / 虚血再灌流障害 … More Except Principal Investigator 活動 / QOL / 遠隔看護 / リハビリテーション / 膵がん / 膵癌 / 一次線毛 / 新規臨床病期システム / 局所進行膵癌 / 境界切除可能膵癌 / 局所進行切除不能膵癌 / 免疫栄養指標 / 化学放射線治療 / 生物学的悪性度 / 浸潤性膵管癌 Less

患者のフィジビリティを高める遠隔看護システム併用型「膵がんリハプログラム」の開発
- Principal Investigator
  
  佐藤菜保子
- Project Period (FY)
  2024 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 58060:Clinical nursing-related
- Research Institution
  Fukushima Medical University
Functional abnormalities of primary cilia in pancreatic cancer and their linkage to clinicopathological characteristics
- Principal Investigator
  
  UCHIDA KATSUNORI
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Mie University
Establishment and therapeutic application of a new clinical staging system based on the biological features of pancreatic adenocarcinoma
- Principal Investigator
  
  Isaji Shuji
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Mie University
The challenge to the liver transplantation by a fatty liver.- Treatment strategy for inflammation and coagulation by ischemia reperfusion injury.Principal Investigator
- Principal Investigator
  
  KISHIWADA MASASHI
- Project Period (FY)
  2010 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  General surgery
- Research Institution
  Mie University
Does the liver transplant from fatty liver become possible?- Ischemia reperfusion injury and liver transplantation model in rat.Principal Investigator
- Principal Investigator
  
  KISHIWADA Masashi
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (Start-up)
- Research Field
  
  General surgery
- Research Institution
  Mie University

All 2020 2019 2018 2017 2014 2013 2012 2011 2010 2009 2008

All Journal Article Presentation

[Journal Article] Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma2020
- Author(s)
  Kato Hiroyuki、Kishiwada Masashi、Hayasaki Aoi、Chipaila Jackson、Maeda Koki、Noguchi Daisuke、Gyoten Kazuyuki、Fujii Takehiro、Iizawa Yusuke、Tanemura Akihiro、Murata Yasuhiro、Kuriyama Naohisa、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji、Mizuno Shugo
- Journal Title
  
  Annals of Surgery
  
  Volume: - Issue: 5 Pages: e698-e707
- DOI
  10.1097/sla.0000000000004148
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients2019
- Author(s)
  Ichikawa Ken、Mizuno Shugo、Hayasaki Aoi、Kishiwada Masashi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Murata Yasuhiro、Azumi Yoshinori、Kuriyama Naohisa、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Cancers
  
  Volume: 11(4) Issue: 4 Pages: 514-514
- DOI
  10.3390/cancers11040514
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy2019
- Author(s)
  Jaseanchiun Warakorn、Kato Hiroyuki、Hayasaki Aoi、Fujii Takehiro、Iizawa Yusuke、Tanemura Akihiro、Murata Yasuhiro、Azumi Yoshinori、Kuriyama Naohisa、Kishiwada Masashi、Mizuno Shugo、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Pancreatology
  
  Volume: 19(2) Issue: 2 Pages: 307-315
- DOI
  10.1016/j.pan.2019.01.020
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019
- Author(s)
  Hayasaki Aoi、Murata Yasuhiro、Usui Masanobu、Hibi Taemi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Azumi Yoshinori、Kuriyama Naohisa、Kishiwada Masashi、Mizuno Shugo、Sakurai Hiroyuki、Uchida Katsunori、Isaji Shuji
- Journal Title
  
  BioMed Research International
  
  Volume: 2019 Pages: 1-12
- DOI
  10.1155/2019/5738614
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor2019
- Author(s)
  Takeuchi Taijiro、Mizuno Shugo、Murata Yasuhiro、Hayasaki Aoi、Kishiwada Masashi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Kuriyama Naohisa、Azumi Yoshinori、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Pancreas
  
  Volume: 48(2) Issue: 2 Pages: 281-291
- DOI
  10.1097/mpa.0000000000001227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019
- Author(s)
  Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreas.
  
  Volume: 48(2) Pages: 281-291
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.2019
- Author(s)
  Jaseanchiun W, Kato H, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreatology.
  
  Volume: 19(2) Pages: 307-315
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.2019
- Author(s)
  Ichikawa K, Mizuno S, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Isaji S
- Journal Title
  
  Cancers (Basel).
  
  Volume: 11(4).
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.2018
- Author(s)
  Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H.
- Journal Title
  
  Cancers (Basel).
  
  Volume: 10(3)
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.2018
- Author(s)
  Isaji S, Mizuno S, Windsor JA, Bassi C, Fernandez-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL.
- Journal Title
  
  Pancreatology.
  
  Volume: 18(1) Pages: 2-11
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of history of splenectomy : the significance of ADAMTS13 and graft function2014
- Author(s)
  Nobuoka Y, Wada H, Mizuno S, Kishiwada M, Usui M, Sakurai H, Tabata M, Kobayashi T, Nobori T, Uemoto S, Isaji S.
- Journal Title
  
  Int J Hematol
  
  Volume: 99 Pages: 418-428
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791247
[Journal Article] Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats : simulated model of small-for-size graft in living donor liver transplantation2014
- Author(s)
  Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.
- Journal Title
  
  Transplant Proc.
  
  Volume: 46 Pages: 1107-1111
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791247
[Journal Article] Thrombomodulin administration attenuates ischemoa-reperfusion injury of the remnant liver after 70% hepatectomy in Rats: simulated model of small-for-size graft in living donor liver transplantation2014
- Author(s)
  Tanemura　A, Kuriyama N, Azumi I, Ohsawa M, Kishiwada M, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.
- Journal Title
  
  Transplantation proceedings
  
  Volume: XX
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791247
[Journal Article] Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of history of splenectomy: the significance of ADAMTS13 and graft function.2014
- Author(s)
  Nobuoka Y1, Wada H, Mizuno S, Kishiwada M, Usui M, Sakurai H, Tabata M, Kobayashi T, Nobori T, Uemoto S, Isaji S.
- Journal Title
  
  Int J Hematol.
  
  Volume: 99 Issue: 4 Pages: 418-428
- DOI
  10.1007/s12185-014-1543-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791247
[Journal Article] Borderline resectable膵癌とは?2011
- Author(s)
  岸和田昌之
- Journal Title
  
  胆と膵
  
  Volume: 32 Pages: 571-577
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791247
[Journal Article] The cytoprotective effects of addition of activated protein C into preservation solution on small-for-size grafts in rats.2010
- Author(s)
  Kuriyama N, Isaji S, Hamada T, Kishiwada M, Ohsawa I, Usui M, Sakurai H, Tabata M, Hayashi T, Suzuki K.
- Journal Title
  
  Liver Transpl 16(1)
  
  Pages: 1-11
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890105
[Journal Article] Regulatory mechanisms of C4b-binding protein (C4BP)alpha and beta expression in rat hepatocytes by lipopolysaccharide and interleukin-6.2008
- Author(s)
  Kishiwada M, Hayashi T, Yuasa H, Fujii K, Nishioka J, Akita N, Tanaka H, Ido M, Okamoto T, Gabazza EC, Isaji S, Suzuki K.
- Journal Title
  
  J Thromb Haemost 6(11)
  
  Pages: 1858-67
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890105
[Presentation] 局所進行膵癌に対するgemcitabine+S1併用放射線化学療法の予後予測　EUS-FNAB検体中hENT1・DPD発現と予後との関連性2020
- Author(s)
  山田玲子, 服部愛司, 倉田一成, 重福亜紀奈, 坪井順哉, 井上宏之, 早崎碧泉, 村田泰洋, 岸和田昌之, 水野修吾, 伊佐地秀司, 竹井謙之
- Organizer
  第106回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌における術前化学放射線治療の治療成績　biological borderline膵癌に対する有効性の検討2020
- Author(s)
  村田泰洋, 早崎碧泉, 飯澤裕介, 藤井武宏, 加藤宏之, 種村彰洋, 栗山直久, 岸和田昌之, 水野修吾, 櫻井洋至, 伊佐地秀司
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 進行膵癌に対するConversion surgery　局所進行膵癌に対する化学放射線先行療法後の治療成績-診断時因子に注目して2020
- Author(s)
  岸和田昌之, 早崎碧泉, 尭天一亨, 藤井武宏, 飯澤祐介, 村田泰洋, 種村彰洋, 栗山直久, 櫻井洋至, 水野修吾
- Organizer
  第75回日本消化器外科学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 長期成績からみた膵癌に対する集学的治療の評価　局所進行切除不能膵癌に対する化学放射線先行療法後の治療成績2020
- Author(s)
  岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 加藤宏之, 村田泰洋, 種村彰洋, 栗山直久, 水野修吾, 櫻井洋至, 伊佐地秀司
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌に対する術前化学放射線治療の臨床的意義　up-front surgeryとの後方視的比較検討2020
- Author(s)
  村田泰洋, 尭天一亨, 早崎碧泉, 藤井武宏, 飯澤祐介, 種村彰洋, 栗山直久, 岸和田昌之, 櫻井洋至, 水野修吾
- Organizer
  第75回日本消化器外科学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌における術前化学放射線治療の臨床的意義　術後早期再発症例の検討2019
- Author(s)
  村田泰洋, 早崎碧泉, 飯澤裕介, 藤井武宏, 加藤宏之, 種村彰洋, 栗山直久, 安積良紀, 岸和田昌之, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行切除不能膵癌に対するConversion surgeryの適応決定における術前癌胎児性抗原(CEA)の重要性　術直前CEA値と切除後予後に着目した臨床的研究2019
- Author(s)
  加藤宏之, 岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 村田泰洋, 種村彰洋, 安積良紀, 栗山直久, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌に対する術前化学放射線療法の治療成績　動脈浸潤と組織学効果に注目して2019
- Author(s)
  岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 加藤宏之, 村田泰洋, 種村彰洋, 栗山直久, 安積良紀, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第50回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Treatment strategy for R and BR pancreatic cancer patients undergoing preoperative chemoradiotherapy according to anatomical, biological and conditional factors2019
- Author(s)
  Shugo Mizuno, Aoi Hayasaki, Masashi Kishiwada, Hiroyuki Kato, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Yoshinori Azumi, Masanobu Usui, Hiroyuki Sakurai, Shuji Isaji
- Organizer
  第31回日本肝胆膵外科学会・学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Impact of preoperative chemoradiotherapy for unresectable locally advanced pancreatic cancer paying attention to pre- and post-CRT biological and conditional factors2019
- Author(s)
  Masashi Kishiwada, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Hiroyuki Kato, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Yoshinori Azumi, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Shuuji Isaji
- Organizer
  第31回日本肝胆膵外科学会・学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 放射線化学療法の抗腫瘍効果に着目した膵癌治療前予後予測におけるノモグラムの有用性2018
- Author(s)
  加藤　宏之、岸和田　昌之、早崎　碧泉、藤井　武宏、飯澤　祐介、種村　彰洋、村田　泰洋、栗山　直久、安積　良紀、水野　修吾、臼井　正信、櫻井　洋至、小椋　透、伊佐地　秀司
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌患者における化学放射線治療施行前後での炎症/免疫栄養指標と予後との関連性について2018
- Author(s)
  市川　健、水野修吾、早崎碧泉、岸和田昌之、飯澤祐介、加藤宏之、村田泰洋、種村彰洋、栗山直久、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第118回日本外科学会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所性膵癌に対する化学放射線療法施行例における炎症/免疫栄養指標と予後の関係2018
- Author(s)
  市川　健、水野　修吾、早崎　碧泉、岸和田　昌之、飯澤　祐介、加藤　宏之、村田　泰洋、種村　彰洋、栗山　直久、臼井　正信、櫻井　洋至、伊佐地　秀司
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Borderline resectable膵癌の国際コンセンサス2017からみた局所性膵癌の治療戦略2018
- Author(s)
  伊佐地　秀司、水野　修吾、岸和田　昌之、早崎　碧泉
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌における術前放射線化学療法施行後、遠隔転移発生の危険因子解析2017
- Author(s)
  加藤　宏之、水野修吾、早崎碧泉、尭天一亨、飯澤祐介　種村彰洋、村田泰洋、安積良紀、栗山直久、岸和田昌之、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第48回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Predictive nomogram for interval distant metastases of locally advanced pancreatic ductal carcinoma after preoperative gemcitabine based chemoradiotherapy. -Clinical importance of biological and physiological markers-2017
- Author(s)
  加藤　宏之、水野修吾、小倉透、早崎碧泉、岸和田昌之、栗山直久、安積良紀、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第29回　肝胆膵外科学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌の治療前予後予測を目的としたPredictive nomogramの作成2017
- Author(s)
  加藤　宏之、岸和田昌之、水野修吾、尭天一亨、早崎碧泉、飯澤祐介、種村彰洋、村田泰洋、安積良紀、栗山直久、臼井正信、櫻井洋至、小倉透、伊佐地秀司
- Organizer
  JDDW2017
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌に対する治療前予後予測は可能か？- 放射線化学療法前予後因子の解析とpredictive nomogramの作成-2017
- Author(s)
  加藤　宏之、岸和田昌之、尭天一亨、早崎碧泉、松井俊樹、飯澤祐介、種村彰洋、村田泰洋、安積良紀、栗山直久、水野修吾、臼井正信、櫻井洋至、伊佐地秀司、小椋透
- Organizer
  第117回日本外科学会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation2013
- Author(s)
  Takahashi N, Wada H , Usui M, Iizawa Y, Sato R, Fujii T, Tanemura A, Kuriyama N, Azumi Y, Osawa I, Kishiwada M, Mizuno S, Sakurai H, Tabata M, Isaji S
- Organizer
  American transplant congress
- Place of Presentation
  シアトル,アメリカ
- Year and Date
  2013-05-20
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 生体肝移植グラフトを想定した、ラット70％肝切除後残存肝虚血再還流障害におけるトロンボモジュリンの肝保護効果について2013
- Author(s)
  種村彰洋、栗山直久、安積良紀、大澤一郎、岸和田昌之、水野修吾、臼井正信、櫻井洋至、田端正己、伊佐地秀司
- Organizer
  第113回日本外科学会
- Place of Presentation
  博多
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 生体肝移植術後血小板値はなぜ低下するのか? -ADAMTS13の変動から見たグラフト肝生体肝移植における予後予測-ADAMSTS13, VWFpp, TM, Tenascin-Cに着目して, 微小循環障害と予後の観点から2013
- Author(s)
  高橋直樹, 臼井正信, 種村彰洋, 栗山直久, 水野修吾, 安積良紀, 岸和田昌之,大澤一郎, 櫻井洋至, 田端正己, 伊佐地秀司, 和田英夫, 吉田利通
- Organizer
  第31回日本肝移植研究会
- Place of Presentation
  熊本
- Year and Date
  2013-07-04
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats : simulated model of small-for-size graft in living donor liver transplantation2013
- Author(s)
  Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M , Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.
- Organizer
  第13回アジア移植学会議
- Place of Presentation
  京都
- Year and Date
  2013-09-04
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 生体肝移植を想定した, ラット肝切除後残存肝虚血再還流障害におけるトロンボモジュリンの肝保護効果について2013
- Author(s)
  種村彰洋, 栗山直久, 安積良紀, 大澤一郎, 岸和田昌之,水野修吾, 臼井正信, 櫻井洋至, 田端正己, 伊佐地秀司
- Organizer
  第113回日本外科学会
- Place of Presentation
  福岡
- Year and Date
  2013-03-05
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 脾摘出後肝硬変患者にはなぜ門脈血栓が高率に発生するのか？　ADAMATS13に着目して2013
- Author(s)
  高橋直樹、臼井正信、安積良紀、栗山直久、大澤一郎、岸和田昌之、水野修吾、櫻井洋至、田端正己、伊佐地秀司
- Organizer
  第25回日本肝胆膵外科学会学術集会
- Place of Presentation
  宇都宮
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 生体肝移植において高齢ドナー肝がドナー, レシピエントに与える影響～術後肝再生, ADAMTS13の推移～2012
- Author(s)
  種村彰洋, 水野修吾, 栗山直久, 大澤一郎, 岸和田昌之, 濱田賢司, 臼井正信, 櫻井洋至, 田端正己, 伊佐地秀司
- Organizer
  第67回日本消化器外科学会集会
- Place of Presentation
  富山
- Year and Date
  2012-07-18
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 生体肝移植周術期における深在性真菌感染に対する早期診断と予防-真菌PCRと周術期経腸栄養に注目して2011
- Author(s)
  岸和田昌之
- Organizer
  第24回日本外科感染症学会総会
- Place of Presentation
  三重
- Year and Date
  2011-12-02
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 生体肝移植術後血小板値はなぜ低下するのか? ADAMTS13の変動から見たグラフト肝微小循環障害と予後の観点から2011
- Author(s)
  信岡祐, 水野修吾, 和田秀夫, 大澤一郎, 岸和田昌之, 濱田賢司, 臼井正信, 櫻井洋至, 田端正己, 伊佐地秀司
- Organizer
  第23回日本肝胆膵外科学会
- Place of Presentation
  東京
- Year and Date
  2011-06-09
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] 進行膵癌100例に対する術前化学放射線療法の治療成績-NCCNガイドラインのresectabilityに注目して2011
- Author(s)
  岸和田昌之
- Organizer
  第23回肝胆膵外科学会
- Place of Presentation
  東京
- Year and Date
  2011-06-08
- Data Source
  KAKENHI-PROJECT-22791247
[Presentation] The Effect of Thrombomodulin on liver cells in Hepatic Ischemia Reperfusion Injury2009
- Author(s)
  Kishiwada M, Kuriyama N, Hamada T, Mizuno S, Usui M, Sakurai S, Tabata M, Hayashi T, Suzuki K, Isaji S
- Organizer
  学会名: American transplant Congress 2009
- Place of Presentation
  Bostin, MA, USA
- Data Source
  KAKENHI-PROJECT-20890105
[Presentation] 肝虚血再還流障害モデルラットに対する組換えヒト可溶性トロンボモジュリンの保護効果2009
- Author(s)
  岸和田昌之, 林辰弥, 安積良紀, 栗山直久, 濱田賢司, 水野修吾, 臼井正信, 桜井洋至, 田端正巳, 伊佐地秀司, 鈴木宏治
- Organizer
  第109回日本外科学会
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-20890105
[Presentation] The Effect of Thrombomodulin on liver cells in Hepatic Ischemia Reperfusion Injury2009
- Author(s)
  岸和田昌之
- Organizer
  American transprant congress 2009
- Place of Presentation
  ボストン (アメリカ)
- Year and Date
  2009-06-01
- Data Source
  KAKENHI-PROJECT-20890105
[Presentation] Thrombomodulin Protects Against Hepatic Ischemia Reperfusion Injury in the Rat2008
- Author(s)
  岸和田昌之
- Organizer
  American Transplant Congress 2008
- Place of Presentation
  トロント(カナダ)
- Year and Date
  2008-06-02
- Data Source
  KAKENHI-PROJECT-20890105
[Presentation] Thrombomodulin Protects Against Hepatic Ischemia Reperfusion Injury in the Rat2008
- Author(s)
  Kishiwada M, Isaji S, Kuriyama N, Ohsawa I, Hamada T, Usui M, Sakurai H, Tabata M, Hayashi T, Esteban C. Gabazza, Suzuki K
- Organizer
  American transplant Congress 2008
- Place of Presentation
  Tront、Canada
- Data Source
  KAKENHI-PROJECT-20890105

1. Isaji Shuji (70176121)

# of Collaborated Projects: 1 results

# of Collaborated Products: 26 results
2. UCHIDA KATSUNORI (60362349)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 村田泰洋 (20572655)

# of Collaborated Projects: 1 results

# of Collaborated Products: 25 results
4. 水野修吾 (70335131)

# of Collaborated Projects: 1 results

# of Collaborated Products: 28 results
5. 加藤宏之 (50737004)

# of Collaborated Projects: 1 results

# of Collaborated Products: 23 results
6. 広川佳史 (30322738)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 石井健一朗 (90397513)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 佐藤菜保子 (40457750)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 霜山真 (00626559)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 佐藤大介 (20524573)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 元井冬彦 (30343057)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 中谷直樹 (60422094)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 森下慎一郎 (60635077)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 海野倫明 (70282043)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 奥坂拓志 (70501849)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Kishiwada Masashi 岸和田 昌之

岸和田 昌之 キシワダ マサシ

KISHIWADA Masashi 岸和田 昌之

Research Projects

Research Products

Co-Researchers

患者のフィジビリティを高める遠隔看護システム併用型「膵がんリハプログラム」の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Functional abnormalities of primary cilia in pancreatic cancer and their linkage to clinicopathological characteristics

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment and therapeutic application of a new clinical staging system based on the biological features of pancreatic adenocarcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The challenge to the liver transplantation by a fatty liver.- Treatment strategy for inflammation and coagulation by ischemia reperfusion injury.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Does the liver transplant from fatty liver become possible?- Ischemia reperfusion injury and liver transplantation model in rat.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019

Author(s)

Journal Title

Data Source

[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.2019

Author(s)

Journal Title

Data Source

[Journal Article] Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.2019

Author(s)

Journal Title

Data Source

[Journal Article] Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.2018

Author(s)

Journal Title

Data Source

[Journal Article] International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.2018

Author(s)

Journal Title

Kishiwada Masashi 岸和田昌之

岸和田昌之キシワダマサシ

KISHIWADA Masashi 岸和田昌之

[Presentation] 局所進行膵癌に対するgemcitabine+S1併用放射線化学療法の予後予測　EUS-FNAB検体中hENT1・DPD発現と予後との関連性2020

[Presentation] 切除可能膵癌における術前化学放射線治療の治療成績　biological borderline膵癌に対する有効性の検討2020

[Presentation] 進行膵癌に対するConversion surgery　局所進行膵癌に対する化学放射線先行療法後の治療成績-診断時因子に注目して2020

[Presentation] 長期成績からみた膵癌に対する集学的治療の評価　局所進行切除不能膵癌に対する化学放射線先行療法後の治療成績2020

[Presentation] 切除可能膵癌に対する術前化学放射線治療の臨床的意義　up-front surgeryとの後方視的比較検討2020

[Presentation] 切除可能膵癌における術前化学放射線治療の臨床的意義　術後早期再発症例の検討2019

[Presentation] 局所進行切除不能膵癌に対するConversion surgeryの適応決定における術前癌胎児性抗原(CEA)の重要性　術直前CEA値と切除後予後に着目した臨床的研究2019

[Presentation] 局所進行膵癌に対する術前化学放射線療法の治療成績　動脈浸潤と組織学効果に注目して2019